BioWorld Asia

April 7, 2010

Convoluted Rules, Bureaucracy Threaten UK Clinical Research

LONDON - The UK government has ordered a rapid and independent review of how clinical trials are regulated, amid evidence that complex and cumbersome rules are driving such research overseas. (BioWorld International) Read More

€33.1M Financing Gives VC Big Slice of Epigenomics

No Abstract Read More

Study of Common Copy Number Variants Ends in Disappointment

BiondVax Strives to Put an End to Annual Flu Vaccine Treadmill

Russia's Protek Seeking $400M in International Public Offering

Deinove Seeking $20M IPO to Fund Ethanol Operation

Horizon, Nitec Merger Creates a New Player in Pain Market

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 3, 2026

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...